Abstract
An impairment of prefrontal cortical functioning in schizophrenia (‘hypofrontality’) has been suggested by clinical, neuroimaging, and postmortem brain tissue studies. We used Western immunoblot and Northern hybridization analyses of postmortem brain tissue obtained from 14 schizophrenic patients and 12 control patients of similar ages to measure tissue levels of synaptophysin (a structural synaptic vesicle protein) and of SNAP-25 (a 25-kDa presynaptic protein), and their encoding mRNAs, in Brodmann's area 10 of prefrontal cortex. There were significant decreases in tissue levels of both of these proteins in prefrontal cortex of schizophrenic patients relative to controls. In contrast, tissue levels for the mRNAs encoding these proteins were not decreased in schizophrenic patients. Subsequent labeling of the same Western immunoblots showed no difference in tissue levels of glial fibrillary acidic protein (GFAP) in schizophrenic and control patients. Similarly, subsequent hybridization of the same Northern hybridization membranes showed no difference in tissue levels of GFAP mRNA or of 28S rRNA in schizophrenic and control patients. These alterations in tissue levels of synaptophysin and SNAP-25 are consistent with the idea that the clinically observed ‘hypofrontality’ of schizophrenia arises from abnormalities of synaptic number or structural integrity in prefrontal cortex.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karson, C., Mrak, R., Schluterman, K. et al. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for ‘hypofrontality’. Mol Psychiatry 4, 39–45 (1999). https://doi.org/10.1038/sj.mp.4000459
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4000459
- Springer Nature Limited
Keywords
This article is cited by
-
Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects
Molecular Psychiatry (2020)
-
Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures
Molecular Psychiatry (2019)
-
Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review
Molecular Psychiatry (2016)
-
Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist
Psychopharmacology (2015)
-
Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction
Molecular Psychiatry (2012)